These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 38861426)
1. Preventing tuberculosis with community-based care in an HIV-endemic setting: a modelling analysis. Ross JM; Greene C; Broshkevitch CJ; Dowdy DW; van Heerden A; Heitner J; Rao DW; Roberts DA; Shapiro AE; Zabinsky ZB; Barnabas RV J Int AIDS Soc; 2024 Jun; 27(6):e26272. PubMed ID: 38861426 [TBL] [Abstract][Full Text] [Related]
2. Preventing tuberculosis with community-based care in an HIV-endemic setting: a modeling analysis. Ross JM; Greene C; Bayer CJ; Dowdy DW; van Heerden A; Heitner J; Rao DW; Roberts DA; Shapiro AE; Zabinsky ZB; Barnabas RV medRxiv; 2023 Aug; ():. PubMed ID: 37662260 [TBL] [Abstract][Full Text] [Related]
3. Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness. Nsengiyumva NP; Campbell JR; Oxlade O; Vesga JF; Lienhardt C; Trajman A; Falzon D; Den Boon S; Arinaminpathy N; Schwartzman K PLoS Med; 2022 Jun; 19(6):e1004032. PubMed ID: 35696431 [TBL] [Abstract][Full Text] [Related]
4. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis. Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study. Mafirakureva N; Mukherjee S; de Souza M; Kelly-Cirino C; Songane MJP; Cohn J; Lemaire JF; Casenghi M; Dodd PJ PLoS Med; 2023 Sep; 20(9):e1004285. PubMed ID: 37672524 [TBL] [Abstract][Full Text] [Related]
6. Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis. Ryckman T; Weiser J; Gombe M; Turner K; Soni P; Tarlton D; Mazhidova N; Churchyard G; Chaisson RE; Dowdy DW Lancet Glob Health; 2023 Aug; 11(8):e1205-e1216. PubMed ID: 37474228 [TBL] [Abstract][Full Text] [Related]
7. Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: a qualitative study of adolescents, caretakers and health workers. Amuge PM; Ndekezi D; Mugerwa M; Bbuye D; Rutebarika DA; Kizza L; Namugwanya C; Baita A; Elyanu PJ; Ntege PN; Kiragga D; Birungi C; Kekitiinwa AR; Kiragga A; Sekadde MP; Salazar NA; Mandalakas AM; Musoke P AIDS Res Ther; 2024 Aug; 21(1):59. PubMed ID: 39210349 [TBL] [Abstract][Full Text] [Related]
8. Incidence of active tuberculosis among people living with HIV receiving long-term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy. Suwanpimolkul G; Gatechompol S; Kawkitinarong K; Ueaphongsukkit T; Sophonphan J; Siriyakorn N; Jirajariyavej S; Khusuwan S; Panarat P; Wannalerdsakun S; Saetiew N; Chayangsu S; Wiwatrojanagul S; Noopetch P; Danpornprasert P; Mekviwattanawong S; Fujitnirun C; Lertpiriyasuwat C; Han WM; Kerr SJ; Ruxrungtham K; Avihingsanon A; J Int AIDS Soc; 2022 Apr; 25(4):e25900. PubMed ID: 35384317 [TBL] [Abstract][Full Text] [Related]
9. New opportunities in tuberculosis prevention: implications for people living with HIV. González Fernández L; Casas EC; Singh S; Churchyard GJ; Brigden G; Gotuzzo E; Vandevelde W; Sahu S; Ahmedov S; Kamarulzaman A; Ponce-de-León A; Grinsztejn B; Swindells S J Int AIDS Soc; 2020 Jan; 23(1):e25438. PubMed ID: 31913556 [TBL] [Abstract][Full Text] [Related]
11. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial. Thomas R; Probert WJM; Sauter R; Mwenge L; Singh S; Kanema S; Vanqa N; Harper A; Burger R; Cori A; Pickles M; Bell-Mandla N; Yang B; Bwalya J; Phiri M; Shanaube K; Floyd S; Donnell D; Bock P; Ayles H; Fidler S; Hayes RJ; Fraser C; Hauck K; Lancet Glob Health; 2021 May; 9(5):e668-e680. PubMed ID: 33721566 [TBL] [Abstract][Full Text] [Related]
12. Community health workers can be trained to identify patients eligible for tuberculosis preventive therapy, but encounter barriers to programme implementation in KwaZulu-Natal, South Africa. Norton S; Moll AP; Madi J; Nkomo N; Brooks RP; Andrews L; Shenoi SV Afr J AIDS Res; 2023 Jul; 22(2):131-135. PubMed ID: 37337826 [TBL] [Abstract][Full Text] [Related]
13. Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review. Gebreegziabher SB; Ashuro AA; Kumssa TH; Teferi MY; Alemayue EA; Datiko DG; Yimer SA; Shagre MB BMC Infect Dis; 2024 May; 24(1):499. PubMed ID: 38760665 [TBL] [Abstract][Full Text] [Related]
14. Modeling the impact of universal tuberculosis molecular testing and timing of tuberculosis preventive treatment during antiretroviral therapy initiation in South Africa. Balasubramanian R; Shearer K; Mudzengi D; Hippner P; Golub JE; Chihota V; Hoffmann CJ; Kendall EA AIDS; 2023 Dec; 37(15):2371-2379. PubMed ID: 37650763 [TBL] [Abstract][Full Text] [Related]
15. Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence. Currie CS; Floyd K; Williams BG; Dye C BMC Public Health; 2005 Dec; 5():130. PubMed ID: 16343345 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of point-of-care testing with task-shifting for HIV care in South Africa: a modelling study. Sharma M; Mudimu E; Simeon K; Bershteyn A; Dorward J; Violette LR; Akullian A; Abdool Karim SS; Celum C; Garrett N; Drain PK Lancet HIV; 2021 Apr; 8(4):e216-e224. PubMed ID: 33347810 [TBL] [Abstract][Full Text] [Related]
17. Estimating the contribution of transmission in primary healthcare clinics to community-wide TB disease incidence, and the impact of infection prevention and control interventions, in KwaZulu-Natal, South Africa. McCreesh N; Karat AS; Govender I; Baisley K; Diaconu K; Yates TA; Houben RM; Kielmann K; Grant AD; White R BMJ Glob Health; 2022 Apr; 7(4):. PubMed ID: 35396264 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis. Smith JA; Sharma M; Levin C; Baeten JM; van Rooyen H; Celum C; Hallett TB; Barnabas RV Lancet HIV; 2015 Apr; 2(4):e159-68. PubMed ID: 25844394 [TBL] [Abstract][Full Text] [Related]
19. Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial. Barnabas RV; Szpiro AA; van Rooyen H; Asiimwe S; Pillay D; Ware NC; Schaafsma TT; Krows ML; van Heerden A; Joseph P; Shahmanesh M; Wyatt MA; Sausi K; Turyamureeba B; Sithole N; Morrison S; Shapiro AE; Roberts DA; Thomas KK; Koole O; Bershteyn A; Ehrenkranz P; Baeten JM; Celum C; Lancet Glob Health; 2020 Oct; 8(10):e1305-e1315. PubMed ID: 32971053 [TBL] [Abstract][Full Text] [Related]
20. Tuberculosis Preventive Treatment Update - U.S. President's Emergency Plan for AIDS Relief, 36 Countries, 2016-2023. Ajiboye AS; O'Connor S; Smith JP; Ahmedov S; Coggin WL; Charles M; Ghosh S; Pierre P; Shah N; Teran RA; Moonan PK; Date A MMWR Morb Mortal Wkly Rep; 2024 Mar; 73(11):233-238. PubMed ID: 38512767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]